Mitochondrial DNA alterations in precision oncology: Emerging roles in diagnostics and therapeutics

Alexis Germán Murillo Carrasco1, Roger Chammas1, Tatiane Katsue Furuya1

  • 1Centro de Investigação Translacional em Oncologia (LIM24), Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil; Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, Brazil.

PubMed

Insights

Mitochondrial DNA (mtDNA) alterations are crucial biomarkers in cancer, aiding diagnosis, progression monitoring, and predicting treatment resistance. Their role in precision oncology and theranostics is rapidly expanding.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Mitochondria are vital organelles involved in cellular functions like ATP production and apoptosis.
  • Mitochondrial DNA (mtDNA) alterations are increasingly recognized for their role in disease development, particularly cancer.
  • The unique properties of mtDNA make it a promising source for cancer biomarkers.

Purpose of the Study:

  • To review the emerging roles of mtDNA alterations in precision oncology.
  • To emphasize the potential of mtDNA alterations in theranostics (diagnosis and therapy).
  • To explore the integration of mtDNA-based diagnostics with current cancer treatment strategies.

Main Methods:

  • Review of current literature on mtDNA alterations in cancer.
  • Exploration of mechanisms linking mtDNA mutations to tumorigenesis and therapy resistance.
  • Discussion of experimental tools and models for investigating mtDNA alterations, including advanced sequencing and animal models.

Main Results:

  • mtDNA alterations serve as valuable biomarkers for cancer diagnosis, monitoring, metastasis detection, and predicting treatment resistance.
  • mtDNA mutations contribute to cancer development and influence therapy resistance.
  • Heteroplasmy (coexistence of different mtDNA types) plays a significant role in cancer biology.

Conclusions:

  • mtDNA alterations hold significant promise for advancing precision oncology and theranostics.
  • Integrating mtDNA diagnostics with therapeutic strategies can personalize cancer care.
  • Further research using advanced tools is essential to fully leverage mtDNA alterations in cancer management.

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.4K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
7.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.7K